Intravaginal and menstrual practices among women working in food and recreational facilities in mwanza, tanzania: Implications for microbicide trials

AIDS and Behavior

Volumn 14, Issue 5, 2010, Pages 1169-1181

  Allen, Caroline F ^a   Desmond, Nicola ^a,b   Chiduo, Betty ^b   Medard, Lemmy ^b   Lees, Shelley S ^b,c   Vallely, Andrew ^c,d   Francis, Suzanna C ^b,c   Ross, David A ^c   Hayes, Richard J ^c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d African Medical and Research Foundation Mwanza   (Tanzania)

Author keywords

Africa; HIV; Prevention of sexual transmission; Vaginal microbicides; Vaginal practices; Women

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ARTICLE; DRUG EFFECT; EMPLOYMENT; FEMALE; FOOD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYGIENE; INFORMATION PROCESSING; INTRAVAGINAL DRUG ADMINISTRATION; MALE; MENSTRUATION; PHASE 3 CLINICAL TRIAL (TOPIC); QUALITATIVE RESEARCH; RECREATION; SEXUALLY TRANSMITTED DISEASE; TANZANIA; VAGINA; WORKPLACE;

ADMINISTRATION, INTRAVAGINAL; ADULT; ANTI-INFECTIVE AGENTS; CLINICAL TRIALS, PHASE III AS TOPIC; EMPLOYMENT; FEMALE; FOCUS GROUPS; FOOD; HIV INFECTIONS; HUMANS; HYGIENE; MALE; MENSTRUATION; QUALITATIVE RESEARCH; RECREATION; SEXUALLY TRANSMITTED DISEASES, VIRAL; TANZANIA; VAGINA; WORKPLACE; YOUNG ADULT;

EID: 79952112544     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9750-8     Document Type: Article

References (46)

1. Brown JE, Brown RC. Traditional intravaginal practices and the heterosexual transmission of disease: A review. Sex Transm Dis. 2000;27(4):183-7.
2. Gresenguet G, Kreiss JK, Chapko MK, Hillier SL, Weiss NS. HIV infection and vaginal douching in Central Africa. AIDS. 1996;11:101-16.
3. Myer L, Denny L, de Souza M, Wright TC Jr., Kuhn L. Distinguishing the temporal association between women's intravaginal practices and risk of human immunodeficiency virus infection: A prospective study of South African women. Am J Epidemiol. 2006;163(6):552-60.
4. Myer L, Kuhn L, Stein ZA, Wright TC Jr., Denny L. Intravaginal practices, bacterial vaginosis, and women's susceptibility to HIV infection: epidemiological evidence and biological mechanisms. Lancet Inf Dis. 2005;5(12):786-94.
5. McClelland RS, Lavreys L, Hassan W, Mandaliya K, Ndinya-Achola JO, Baeten JM. Vaginal washing and increased risk of HIV-1 acquisition among African women: A 10-year prospective study. AIDS. 2006;20(2):269-73.
6. van de Wijgert JHHM, Morrison CS, Cornelisse PGA, et al. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr. 2008;48(2):203-10.
7. Braunstein S, van de Wijgert J. Preferences and practices related to vaginal lubrication: implications for microbicide acceptability and clinical testing. J Womens Health. 2005;14(5):424-33.
8. Mantell JE, Myer L, Carballo-Dieguez A, et al. Microbicide acceptability research: current approaches and future directions. Soc Sci Med. 2005;60(2):319-30.
9. Lees S, Desmond N, Allen C, Bugeke G, Vallely A, Ross D. Sexual risk behaviour for women working in recreational venues in Mwanza, Tanzania: considerations for the acceptability and use of vaginal microbicide gels. Cult Health Sex. 2009;11(6): 581-95.
10. Martin Hilber A, Chersich M, Van de Wijgert J, Rees H, Temmerman M. Vaginal practices, microbicides and HIV: what do we need to know? Sex Transm Infect. 2007;83:505-8.
11. Martin Hilber A, Hull T, Preston-Whyte E, et al. A cross cultural study of vaginal practices and sexuality: implications for sexual health. Soc Sci Med. 2010;70(3):392-400.
12. Weiss H, Wasserheit J, Barnabas R, Hayes R, Abu-Raddad L. Persisting with prevention: the importance of adherence for HIV prevention. Emerg Themes Epidemiol. 2008;5(1):8.
13. UNAIDS. Report on the global AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS; 2008.
14. Heise LL, Elias C. Transforming AIDS prevention to meet women's needs: A focus on developing countries. Soc Sci Med. 1995;40(7):931-43.
15. Orner P, Harries J, Cooper D, et al. Challenges to microbicide introduction in South Africa. Soc Sci Med. 2006;63(4):968-78.
16. Salter M, Go V, Celentano D, Diener-West M, Nkhoma C, Kumwenda N. The role of men in women's acceptance of an intravaginal gel in a randomized clinical trial in Blantyre, Malawi: A qualitative and quantitative analysis. AIDS Care. 2008;20(7):853-62.
17. Montgomery C, Lees S, Stadler J, Morar N, Ssali A, Mwanza B. The role of partnership dynamics in determining the acceptability of condoms and microbicides. AIDS Care. 2008;20(6):733-40.
18. Koo HP, Woodsong C, Dalberth BT, Viswanathan M, Simons-Rudolph A. Context of acceptability of topical microbicides: Sexual relationships. J Soc Issues. 2005;61(1):67-93.
19. Stirratt MJ, Gordon CM. Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research. Curr HIV/AIDS reports. 2008;5(4):186-92.
20. Padian N, Buvé A, Balkus J, Serwadda D, Cates WJ. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet. 2008;372(9638):585-99.
21. Turner A, Van Damme K, Jamieson D, Khan M, Pettifor A, Swezey T. Predictors of adherent use of diaphragms and microbicide gel in a four-arm, randomized pilot study among female sex workers in Madagascar. Sex Transm Dis. 2009;36:249-57.
22. Allen CF, Lees SS, Desmond N, et al. Validity of coital diaries in a feasibility study for the microbicides development programme trial among women at high risk of HIV/AIDS in Mwanza, Tanzania. Sex Transm Infect. 2007;83:490-7.
23. Van de Wijgert J, Morrison C, Salata R, Padian N. Is vaginal washing associated with increased risk of HIV infection AIDS. 2006;20(9):1347-8.
24. Desmond N, Allen CF, Clift S, et al. A typology of groups at risk of HIV/STI in a gold mining town in north-western Tanzania. Soc Sci Med. 2005;60(8):1739-49.
25. Kapiga SH, Sam NE, Shao JF, et al. HIV-1 epidemic among female bar and hotel workers in northern Tanzania: risk factors and opportunities for prevention. J Acquir Immune Defic Syndr. 2002;29(4):409-17.
26. Watson-Jones D, Weiss HA, Rusizoka M, et al. Risk factors for Herpes simplex virus type 2 and HIV among women at high risk in Northwestern Tanzania: Preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr. 2007;46(5):631-42.
27. Vallely A, Kasindi S, Hambleton IR, et al. Microbicides development program, Tanzania. Baseline characteristics of an occupational cohort and reattendance at 3 months. Sex Transm Dis. 2007;34(9):638-43.
28. Association of Social Anthropologists. Ethical guidelines for good research practice. Association of Social Anthropologists of the UK and Commonwealth. http://www.theasa.org/ethics/guidelines.htm (2008).
29. Van De Wijgert J, Mbizvo M, Dube S, Mwale M, Nyamapfeni P, Padian N. Intravaginal practises in Zimbabwe: which women engage in them and why? Cult Health Sex. 2001;3(2):133-48.
30. Runganga A, Kasule J. The vaginal use of herbs/substances: An HIV transmission facilitatory factor? AIDS Care. 1995;7:639-45.
31. Fonck K, Kaul R, Keli F, et al. Sexually transmitted infections and vaginal douching in a population of female sex workers in Nairobi, Kenya. Sex transm infect. 2001;77(4):271-5.
32. Beksinska ME, Rees H, Kleinschmidt I, McIntyre J. The practice and prevalence of dry sex among men and women in South Africa: A risk factor for sexually transmitted infections? Sex transm infect. 1999;75:178-80.
33. Civic D, Wilson D. Dry sex in Zimbabwe and implications for condom use. Soc Sci Med. 1996;42(1):91-8.
34. Morar NS, Ramjee G, Gouws E, Wilkinson D. Vaginal douching and vaginal substance use among sex workers in KwaZulu-Natal, South Africa. S Afr J Sci. 2003;99(7-8):371-4.
35. Myer L, Denny L, De Souza M, Barone MA, Wright TC, Kuhn L. Intravaginal practices, HIV and other sexually transmitted diseases among South African women. Sex Transm Dis. 2004;31(3): 174-9.
36. Dallabetta GA, Miotti PG, Chiphangwi JD, Liomba G, Canner JK, Saah AJ. Traditional vaginal agents -use and association with HIV-infection in Malawian women. AIDS. 1995;9(3): 293-7.
37. Orubuloye I, Caldwell P, Caldwell J. A note on suspect practices during the AIDS epidemic: vaginal drying and scarification in southwest Nigeria. Health Transit Rev. 1995;5(suppl.):161-5.
38. Global Campaign for Microbicides. Why women should NOT use lemon or lime juice as a microbicide. http://wwwglobalcampaignorg/clientfiles/NEW%20lemon- lime%20juice-June26 doc (2006).
39. Lackman-Smith C, Snyder BA, Luckenbaugh KM, et al., editors. Preclinical evaluations of lemon and lime juice as microbicide candidates. Microbicides 2006. Cape Town, South Africa; 2006.
40. Fletcher P, Harman S, Shattock R, Boothe A, Doncel G. Preclinical evaluation of lime juice as a topical microbicide candidate. Retrovirology. 2008;5(3).
41. Averbach S, Sahin-Hodoglugil N, Musara P, Chipato T, van der Straten A. Duet-for menstrual protection: A feasibility study in Zimbabwe. Contraception. 2009;79:463-8.
42. Francis S, Allen C, Vallely A, et al. Intravaginal practices in a microbicide feasibility study in Mwanza, Tanzania: baseline associations with bacterial vaginosis, sexually transmitted infections and HIV. In: 17th Conference of the international society for STD Research. Seattle, USA; 2007 July 29-August 1.
43. Shah R, Bradbeer C. Women and HIV-revisited ten years on. Int J STD AIDS. 2000;11(5):277-83.
44. Tanfer K, Aral SO. Sexual intercourse during menstruation and self-reported sexually transmitted disease history among women. Sex Transm Dis. 1996;23(5):395-401.
45. Montgomery CM, Gafos M, Lees S, et al. Re-framing microbicide acceptability: findings from the MDP301 trial. Cult Health Sex. 2010;12(6):649-62.
46. Romano J, editor. Characterization of in vitro release and in vivo delivery of TMC120 with an intravaginal ring. In: International AIDS Conference, Toronto; 2006.